Effect of vaccination on immune and clinical responses in glioblastoma multiforme patients

被引：0
|
作者：
Wheeler, C. J. [1 ]
Black, K. L. [1 ]
Liu, G. [1 ]
Mazer, M. [1 ]
Zhang, X. [1 ]
Pepkowitz, S. [1 ]
Goldfinger, D. [1 ]
Ng, H. [1 ]
Irvin, D. K. [1 ]
Yu, J. S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3060
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
    Wheeler, Christopher J.
    Black, Keith L.
    Liu, Gentao
    Mazer, Mia
    Zhang, Xiao-xue
    Pepkowitz, Samuel
    Goldfinger, Dennis
    Ng, Hiushan
    Irvin, Dwain
    Yu, John S.
    [J]. CANCER RESEARCH, 2008, 68 (14) : 5955 - 5964
  • [2] Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
    Wheeler, CJ
    Das, A
    Liu, GT
    Yu, JS
    Black, KL
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5316 - 5326
  • [3] TUMOR AUTOGRAFT RESPONSES IN PATIENTS WITH GLIOBLASTOMA MULTIFORME
    GRACE, JT
    SASABE, T
    METZGAR, RS
    HOLDRIDGE, B
    PERESE, DM
    [J]. JOURNAL OF NEUROSURGERY, 1961, 18 (02) : 159 - &
  • [4] Immune phenotypes predict survival in patients with glioblastoma multiforme
    Haouraa Mostafa
    Andrej Pala
    Josef Högel
    Michal Hlavac
    Elvira Dietrich
    M. Andrew Westhoff
    Lisa Nonnenmacher
    Timo Burster
    Michael Georgieff
    C. Rainer Wirtz
    E. Marion Schneider
    [J]. Journal of Hematology & Oncology, 9
  • [5] Immune phenotypes predict survival in patients with glioblastoma multiforme
    Mostafa, Haouraa
    Pala, Andrej
    Hoegel, Josef
    Hlavac, Michal
    Dietrich, Elvira
    Westhoff, M. Andrew
    Nonnenmacher, Lisa
    Burster, Timo
    Georgieff, Michael
    Wirtz, C. Rainer
    Schneider, E. Marion
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [6] Antitumor vaccination of patients with glioblastoma multiforme: A pilot study to assess feasibility, safety, and clinical benefit
    Steiner, HH
    Bonsanto, MM
    Beckhove, P
    Brysch, M
    Geletneky, K
    Ahmadi, R
    Schuele-Freyer, R
    Kremer, P
    Ranaie, G
    Matejic, D
    Bauer, H
    Kiessling, M
    Kunze, S
    Schirrmacher, V
    Herold-Mende, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4272 - 4281
  • [7] Dendritic Cell Vaccination for Glioblastoma Multiforme: Clinical Experience and Future Directions
    Dejaegher, Joost
    Solie, Lien
    De Vleeschouwer, Steven
    Van Gool, Stefaan W.
    [J]. 2014 6TH INTERNATIONAL ADVANCED RESEARCH WORKSHOP ON IN SILICO ONCOLOGY AND CANCER INVESTIGATION (IARWISOCI), 2014,
  • [8] The effect of hyperglycemia on survival in patients with glioblastoma multiforme
    Derr, R. L.
    Ye, X.
    Isias, M.
    Desideri, S.
    Grossman, S. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
    Izumoto, Shuichi
    Tsuboi, Akihiro
    Oka, Yoshihiro
    Suzuki, Tsuyoshi
    Hashiba, Tetsuo
    Kagawa, Naoki
    Hashimoto, Naoya
    Maruno, Motohiko
    Elisseeva, Olga A.
    Shirakata, Toshiaki
    Kawakami, Manabu
    Oji, Yusuke
    Nishida, Sumiyuki
    Ohno, Satoshi
    Kawase, Ichiro
    Hatazawa, Jun
    Nakatsuka, Shin-icih
    Aozasa, Katsuyuki
    Morita, Satoshi
    Sakamoto, Junichi
    Sugiyama, Haruo
    Yosihmine, Toshiki
    [J]. JOURNAL OF NEUROSURGERY, 2008, 108 (05) : 963 - 971
  • [10] Immune modulation by combined radiation and temozolomide in glioblastoma multiforme patients
    Fadul, Camilo
    Fisher, Jan
    Demidenko, Eugene
    Turk, Mary Jo
    Usherwood, Edward
    Ernstoff, Marc
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 507 - 507
12345